The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease

International Journal of Cardiology

Volumn 108, Issue 2, 2006, Pages 244-250

  Tsagalou, Eleftheria P ^c   Anastasiou Nana, Maria I ^a   Terrovitis, John V ^d   Nanas, Serafim N ^b   Alexopoulos, George P ^a   Kanakakis, John ^a   Nanas, John N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardiomyopathy; Congestive heart failure; Inotropic agents; Intermittent dobutamine; Ischemic heart disease

Indexed keywords

AMIODARONE; DIGOXIN; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; FEMALE; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AMIODARONE; CARDIOMYOPATHY, DILATED; DOBUTAMINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644666816     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.012     Document Type: Article

References (35)

1. A. Mosterd, B. Cost, and A.W. Hoes The prognosis of heart failure in the general population: the Rotterdam study Eur Heart J 22 2001 1318 1327
2. B.A. Bart, L.K. Shaw, and C.B. McCants Jr. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy J Am Coll Cardiol 30 1997 1002 1008
3. M.J. Likoff, S.L. Chandler, and H.R. Kay Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy Am J Cardiol 59 1987 634 638
4. L.W. Stevenson, J.H. Tillisch, and M. Hamilton Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 66 1990 1348 1354
5. M. Anguita, J.M. Arizon, and G. Bueno Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 72 1993 413 417
6. J. Parameshwar, J. Keegan, J. Sparrow, G.C. Sutton, and P.A. Poole-Wilson Predictors of prognosis in severe chronic heart failure Am Heart J 123 1992 421 426
7. A.M. Keogh, D.W. Baron, and J.B. Hickie Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation Am J Cardiol 65 1990 903 908
8. M. Packer, M.R. Bristow, and J.N. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
9. W.S. Colucci, M. Packer, and M.R. Bristow Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. U.S. Carvedilol Heart Failure Study Group Circulation 94 1996 2800 2806
10. M.R. Bristow, E.M. Gilbert, and W.T. Abraham Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 1996 2807 2816
11. M. Packer, W.S. Colucci, and J.D. Sackner-Bernstein Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. PRECISE trial. Prospective randomized evaluation of carvedilol on symptoms and exercise Circulation 94 1996 2793 2799
12. R. Garg, S. Yusuf for the Collaborative Group on ACE Inhibitor Trials Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
13. P. Nony, J.P. Boissel, P. Girard, A. Leizorovicz, M. Lievre, and R. Chifflet Relative efficacy of angiotensin converting enzyme inhibitors mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure Eur Heart J 13 1992 1101 1108
14. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
15. H.C. Doval, D.R. Nul, H.O. Grancelli, S.V. Perrone, G.R. Bortman, and R. Curiel Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 1994 493 498
16. S.N. Singh, R.D. Fletcher, and S.G. Fisher Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure N Engl J Med 333 1995 77 82
17. B.M. Massie, S.G. Fisher, and M. Radford Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators Circulation 93 1996 2128 2134
18. D.M. Mancini, A. Beniaminovitz, and H. Levin Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389
19. S.F. Shakar, W.T. Abraham, and E.M. Gilbert Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure J Am Coll Cardiol 31 1998 1336 1340
20. J.N. Nanas, D.A. Kontoyannis, and G.P. Alexopoulos Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure Chest 119 2001 1173 1178
21. J.N. Nanas, E.P. Tsagalou, and J. Kanakakis Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study Chest 125 2004 1198 1204
22. L.W. Stevenson Clinical use of inotropic therapy for heart failure. Looking backward or forward? Part II: chronic inotropic therapy Circulation 108 2003 492 497
23. C. Indolfi, F. Piscione, and P. Perrone-Filardi Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium Am Heart J 132 1996 542 549
24. G.M. Felker, R.L. Benza, A.B. Chandler OPTIME-CHF Investigators Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 2003 997 1003
25. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds Jr., and J.R. Wilson Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
26. A. Gavazzi, C. Berzuini, and C. Campana Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure J Heart Lung Transplant 16 1997 774 785
27. L.W. Stevenson, L.W. Miller, P. Desvigne-Nickens REMATCH Investigators Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) Circulation 110 2004 975 981
28. C. Panciroli, G. Galloni, and A. Oddone Prognostic value of hyponatremia in patients with severe chronic heart failure Angiology 41 1990 631 638
29. K. Maeda, T. Tsutamoto, and A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 2000 1587 1593
30. M. Kittleson, S. Hurwitz, and M.R. Shah Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality J Am Coll Cardiol 41 2003 2029 2035
31. S.A. Strickberger, J.D. Hummel, and T.G. Bartlett Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT J Am Coll Cardiol 41 2003 1707 1712
32. G.H. Bardy, K.L. Lee, D.B. Mark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
33. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
34. A.J. Moss, W. Zareba, W.J. Hall Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
35. G.W. Dec Jr., I.F. Palacios, and J.T. Fallon Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates and clinical outcome N Engl J Med 312 1985 885 890